FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054289218> ?p ?o ?g. }

• W2054289218 endingPage "877" @default.
• W2054289218 startingPage "873" @default.
• W2054289218 abstract "ObjectiveTo determine the changes in cytokine levels from women with endometriomas who are treated with recombinant interleukin-2 after ultrasound-guided cyst aspiration, and to relate these changes to the clinical results observed in these patients.DesignA double-blind randomized controlled trial.SettingUniversity hospital.Patient(s)Twenty-four women with endometriosis-related symptoms and endometriomas.Intervention(s)Endometriomas in women receiving GnRH analogues and undergoing transvaginal ultrasound-guided cyst aspiration were injected with dextrose that did or did not contain recombinant interleukin-2 (IL-2). Serum samples were collected before and after treatment.Main outcome measure(s)Serum samples were analyzed by enzyme immunoassay to determine the levels of IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and IL-17.Result(s)The cytokine levels after treatment with GnRH analogues and recombinant IL-2 were similar to the initial levels. The patients receiving GnRH analogues without IL-2 had higher IL-1, IL-2, IL-8, and IL-13 levels. Good clinical results were observed in 90% of the patients in the first group but in only 30% of the second one.Conclusion(s)Administration of recombinant IL-2 intracystically decreases cytokine production in women with endometriomas. These results have important implications for the design of future therapies based on immunomodulation, such as using higher or repeated doses of recombinant IL-2 in the cysts. To determine the changes in cytokine levels from women with endometriomas who are treated with recombinant interleukin-2 after ultrasound-guided cyst aspiration, and to relate these changes to the clinical results observed in these patients. A double-blind randomized controlled trial. University hospital. Twenty-four women with endometriosis-related symptoms and endometriomas. Endometriomas in women receiving GnRH analogues and undergoing transvaginal ultrasound-guided cyst aspiration were injected with dextrose that did or did not contain recombinant interleukin-2 (IL-2). Serum samples were collected before and after treatment. Serum samples were analyzed by enzyme immunoassay to determine the levels of IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and IL-17. The cytokine levels after treatment with GnRH analogues and recombinant IL-2 were similar to the initial levels. The patients receiving GnRH analogues without IL-2 had higher IL-1, IL-2, IL-8, and IL-13 levels. Good clinical results were observed in 90% of the patients in the first group but in only 30% of the second one. Administration of recombinant IL-2 intracystically decreases cytokine production in women with endometriomas. These results have important implications for the design of future therapies based on immunomodulation, such as using higher or repeated doses of recombinant IL-2 in the cysts." @default.
• W2054289218 created "2016-06-24" @default.
• W2054289218 creator A5064159354 @default.
• W2054289218 creator A5064774827 @default.
• W2054289218 creator A5069161740 @default.
• W2054289218 date "2005-04-01" @default.
• W2054289218 modified "2023-10-07" @default.
• W2054289218 title "Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage, and intracystic recombinant interleukin-2" @default.
• W2054289218 cites W1543653831 @default.
• W2054289218 cites W1806475030 @default.
• W2054289218 cites W193909914 @default.
• W2054289218 cites W1995996965 @default.
• W2054289218 cites W2005309779 @default.
• W2054289218 cites W2019630312 @default.
• W2054289218 cites W2021982376 @default.
• W2054289218 cites W2032121928 @default.
• W2054289218 cites W2034635082 @default.
• W2054289218 cites W2051981970 @default.
• W2054289218 cites W2055287802 @default.
• W2054289218 cites W2060769801 @default.
• W2054289218 cites W2062507113 @default.
• W2054289218 cites W2064426938 @default.
• W2054289218 cites W2077833571 @default.
• W2054289218 cites W2085340970 @default.
• W2054289218 cites W2085523985 @default.
• W2054289218 cites W2092295906 @default.
• W2054289218 cites W2119774152 @default.
• W2054289218 cites W2133121262 @default.
• W2054289218 cites W2152421826 @default.
• W2054289218 cites W2158499144 @default.
• W2054289218 cites W2238870413 @default.
• W2054289218 cites W2285847197 @default.
• W2054289218 cites W2322448202 @default.
• W2054289218 cites W2401134385 @default.
• W2054289218 cites W2410197530 @default.
• W2054289218 doi "https://doi.org/10.1016/j.fertnstert.2004.10.035" @default.
• W2054289218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15820793" @default.
• W2054289218 hasPublicationYear "2005" @default.
• W2054289218 type Work @default.
• W2054289218 sameAs 2054289218 @default.
• W2054289218 citedByCount "11" @default.
• W2054289218 countsByYear W20542892182016 @default.
• W2054289218 countsByYear W20542892182019 @default.
• W2054289218 countsByYear W20542892182023 @default.
• W2054289218 crossrefType "journal-article" @default.
• W2054289218 hasAuthorship W2054289218A5064159354 @default.
• W2054289218 hasAuthorship W2054289218A5064774827 @default.
• W2054289218 hasAuthorship W2054289218A5069161740 @default.
• W2054289218 hasBestOaLocation W20542892181 @default.
• W2054289218 hasConcept C104317684 @default.
• W2054289218 hasConcept C126322002 @default.
• W2054289218 hasConcept C141071460 @default.
• W2054289218 hasConcept C2778690821 @default.
• W2054289218 hasConcept C2779522080 @default.
• W2054289218 hasConcept C2780597408 @default.
• W2054289218 hasConcept C29456083 @default.
• W2054289218 hasConcept C40767141 @default.
• W2054289218 hasConcept C55493867 @default.
• W2054289218 hasConcept C71924100 @default.
• W2054289218 hasConcept C74172505 @default.
• W2054289218 hasConcept C86803240 @default.
• W2054289218 hasConcept C90924648 @default.
• W2054289218 hasConceptScore W2054289218C104317684 @default.
• W2054289218 hasConceptScore W2054289218C126322002 @default.
• W2054289218 hasConceptScore W2054289218C141071460 @default.
• W2054289218 hasConceptScore W2054289218C2778690821 @default.
• W2054289218 hasConceptScore W2054289218C2779522080 @default.
• W2054289218 hasConceptScore W2054289218C2780597408 @default.
• W2054289218 hasConceptScore W2054289218C29456083 @default.
• W2054289218 hasConceptScore W2054289218C40767141 @default.
• W2054289218 hasConceptScore W2054289218C55493867 @default.
• W2054289218 hasConceptScore W2054289218C71924100 @default.
• W2054289218 hasConceptScore W2054289218C74172505 @default.
• W2054289218 hasConceptScore W2054289218C86803240 @default.
• W2054289218 hasConceptScore W2054289218C90924648 @default.
• W2054289218 hasIssue "4" @default.
• W2054289218 hasLocation W20542892181 @default.
• W2054289218 hasLocation W20542892182 @default.
• W2054289218 hasOpenAccess W2054289218 @default.
• W2054289218 hasPrimaryLocation W20542892181 @default.
• W2054289218 hasRelatedWork W1582580594 @default.
• W2054289218 hasRelatedWork W1954766992 @default.
• W2054289218 hasRelatedWork W1988645453 @default.
• W2054289218 hasRelatedWork W2003635697 @default.
• W2054289218 hasRelatedWork W2414729050 @default.
• W2054289218 hasRelatedWork W3123462835 @default.
• W2054289218 hasRelatedWork W3208449664 @default.
• W2054289218 hasRelatedWork W4210756955 @default.
• W2054289218 hasRelatedWork W4321088342 @default.
• W2054289218 hasRelatedWork W88698947 @default.
• W2054289218 hasVolume "83" @default.
• W2054289218 isParatext "false" @default.
• W2054289218 isRetracted "false" @default.
• W2054289218 magId "2054289218" @default.
• W2054289218 workType "article" @default.